These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 33901207)

  • 1. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S; Spini M; Hua J; Harrison DM
    PLoS One; 2021; 16(4):e0249973. PubMed ID: 33901207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions.
    Donatelli G; Cecchi P; Migaleddu G; Cencini M; Frumento P; D'Amelio C; Peretti L; Buonincontri G; Pasquali L; Tosetti M; Cosottini M; Costagli M
    Neuroimage Clin; 2023; 40():103509. PubMed ID: 37717382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.
    Spini M; Choi S; Harrison DM
    J Neuroimaging; 2020 Jul; 30(4):531-536. PubMed ID: 32569408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H; Krakauer M; Skimminge A; Sellebjerg F; Garde E; Siebner HR; Paulson OB; Hesse D; Hanson LG
    PLoS One; 2013; 8(2):e56375. PubMed ID: 23441184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
    Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
    Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periventricular gradient of T
    Vaneckova M; Piredda GF; Andelova M; Krasensky J; Uher T; Srpova B; Havrdova EK; Vodehnalova K; Horakova D; Hilbert T; Maréchal B; Fartaria MJ; Ravano V; Kober T
    Neuroimage Clin; 2022; 34():103009. PubMed ID: 35561554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W; Zhang Y; Mu K; Pan C; Gauthier SA; Zhu W; Wang Y
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study.
    Wengler K; Ha J; Syritsyna O; Bangiyev L; Coyle PK; Duong TQ; Schweitzer ME; He X
    Magn Reson Imaging; 2020 Jul; 70():126-133. PubMed ID: 32353529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI.
    Choi S; Lake S; Harrison DM
    J Magn Reson Imaging; 2024 Mar; 59(3):941-951. PubMed ID: 37276054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.
    Beck ES; Sati P; Sethi V; Kober T; Dewey B; Bhargava P; Nair G; Cortese IC; Reich DS
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):459-466. PubMed ID: 29439120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
    Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
    Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
    Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
    Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis.
    Müller J; La Rosa F; Beaumont J; Tsagkas C; Rahmanzadeh R; Weigel M; Bach Cuadra M; Gambarota G; Granziera C
    Invest Radiol; 2022 Sep; 57(9):592-600. PubMed ID: 35510874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
    Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study.
    Werring DJ; Brassat D; Droogan AG; Clark CA; Symms MR; Barker GJ; MacManus DG; Thompson AJ; Miller DH
    Brain; 2000 Aug; 123 ( Pt 8)():1667-76. PubMed ID: 10908196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of "black holes".
    Lapucci C; Romano N; Schiavi S; Saitta L; Uccelli A; Boffa G; Pardini M; Signori A; Castellan L; Inglese M; Roccatagliata L
    Eur Radiol; 2020 Jul; 30(7):3843-3851. PubMed ID: 32162002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.